- The study's design and not statistically correct, so this study is not worth noting: Rajeev Karandikar
Manoj Rautela reports:
New Delhi: Looks like W.H.O. I am not doing anything right In India, resentment against him has been increasing after the World Health Organization (WHO) advised him to stop the testing of hydroxychloroquine. India produces the most of this medicine in the world and currently exports the most.
In Bharata, resentment is coming out not only among the common people but also in our institutes and scientists.Its opposition in India is increasing. After the Union Ministry of Health and the Indian Council of Medical Research (ICMR), Shekhar Mande, Director General of the Council of Scientific and Industrial Research (CSIR), Anurag Aggarwal, Director, Institute of Genomics and Integrative Biology (IGIB) Delhi and Rajiv Karanadikar, Director of Chennai Mathematical Institute In a letter to WHO, the decision to put a temporary moratorium on the testing of this drug on the study of the journal Lancet is utterly wrong.
He stated in the letter that the decision to temporarily stop the drug test is not correct and we request the WHO to allow the trials to be resumed as soon as possible for its use in corona cases. These people have also sent their letters by email to Lancet Paper Editor Richard Charles Horton.
It states that the study published in Lancet on HCQ and its effect on chloroquine and covid-19 is not correct. The study that has been done is wrong. Because The study's design and statistic are not correct. In this case, this study is not worth noting. We believe the WHO decision is under question and the statistical review is not correct.
W.H.O. The Corona case is under the same questions. America has announced to end the relationship W.H.O. with. While the US used to provide considerable financial help W.H.O. On, President Trump has already accused W.H.O. The institute is under the control of China. In such a situation, it is not right to question India's medicine hydroxychloroquine. It is not right to recommend stopping the test.
Lancet is a science journal. Lancet, in its study, found that corona patients are not getting any health benefit from this malaria medicine.
The journal's study included 96,000 patients infected with corona. Of these, 15,000 people were given hydroxychloroquine or some other medicine. It was later discovered that there were more deaths in the class eating hydroxychloroquine than other patients. Heart disease problems were also seen in these patients. Among those given hydroxychloroquine, the mortality rate was 18 percent.
Expert researcher Kavita Singh Majila, associated with the pharma sector, says, "Medicines in India are made by proper research and care. This tablet is for malaria. How effective will corona treatment be in a hurry. So in this case Advising to stop the test raises questions at such a time. One step is taken care of. Quality control, research, formulation, production, storage are taken care of. To date the question has not been raised on hydroxychloroquine. Corona disease If this medicine is not working effectively, then there are other institutions that can test and report on it. On a 'Lancet' report, the WHO should thus not advise to stop testing hydroxychloroquine. "
कोई टिप्पणी नहीं:
एक टिप्पणी भेजें